In addition, this case shows that propranolol can be administered safely and has a significant therapeutic effect on Gorham syndrome by reducing circulating VEGF-A rather than by changing VEGF-C or Fms-like tyrosine kinase-1 (FLT-1) levels. The gene discussed is FLT1; the disease is Gorham-Stout disease.